← Back to Patent Explorer
EP0341745B1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Crosslinked carboxy polysaccharides

Assignee: Fidia Farmaceutici SpA
•
Filing: 1989-05-12
•
Granted: 1994-12-14
•
Expires: 2009-05-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Inter and/or intramolecular cross-linked esters of acid polysaccharides are disclosed in which a part or all of the carboxy groups are esterified with hydroxyl groups of the same molecule and/or of different molecules of the acid polysaccharide. These inner cross-linked esters of polysaccharide acids are useful in the field of biodegradable plastic materials, to manufacture sanitary and surgical articles, in the cosmetic and pharmaceutical fields, in the food industry and in many other industrial fields.

Inventors

  • 👤 Francesco Dr. Della Valle
  • 👤 Aurelio Prof. Romeo

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-24 18:57
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0014; C; C08; C08B; C08B15/00; A61K47/00; A61K47/30; A61K47/36; A61K47/38; A61K8/00; A61K8/02; A61K8/0208; A61K8/18; A61K8/72; A61K8/73; A61K8/731; A61K8/733; A61K8/735; A61K8/736; A61L; A61L15/00; A61L15/16; A61L15/22; A61L15/28; A61L15/42; A61L15/425; A61L17/00; A61L17/06; A61L17/10; A61L27/00; A61L27/14; A61L27/20; A61L27/50; A61L27/58; A61L31/00; A61L31/04; A61L31/042; A61Q; A61Q19/00; C08B11/00; C08B11/20; C08B15/005; C08B37/00; C08B37/0006; C08B37/0024; C08B37/0027; C08B37/003; C08B37/006; C08B37/0063; C08B37/0072; C08B37/0084; A61K2800/00; A61K2800/40; A61K2800/57

Claims Analysis

Total Claims: 35
Claim 1
Independent Claim 430 words
A cross-linked hyaluronic acid product wherein the first portion of 1-100% of the carboxyl groups of said hyaluronic acid are cross-linked by ester bonding or lactonic bonding to hydroxyl groups of the same hyaluronic acid molecule and/or to hydroxyl groups of different hyaluronic acid molecules; and the second portion of carboxyl groups if present of said hyaluronic acid are esterified with aliphatic, araliphatic, cycloaliphatic or heterocyclic alcohols, wherein said alcohols of the aliphatic series have a maximum of 34 carbon atoms and may be substituted by one or two functional groups chosen from the group formed by amino, hydroxy, mercapto, aldehydo, ketal, carboxy, hydrocarbyl, and dihydrocarbylamino, ether, ester, thioester, acetal, ketal, carbamidic groups or carbamidic groups substituted by one or more alkyl groups, the hycrocarbyl radicals in these groups having a maximum of 6 functionally modified carbon atoms, and in which such alcohols of the aliphatic series may be interrupted in the carbon atom chain by heteroatoms chosen from the group formed by oxygen, sulfur and nitrogen, and wherein said alcohols of the araliphatic series have only one benzene residue and have an aliphatic chain with a maximum of 4 carbon atoms and wherein the benzene residue may be substituted by between 1 and 3 methyl or hydroxy groups, by halogen atoms, and wherein the aliphatic chain may be substituted by one or two functions chosen from the group consisting of free amino groups or mono- or diethyl groups or by pyrrolidine or piperidine groups, said alcohols of the cycloaliphatic or aliphatic-cycloaliphatic series are mono- or polycyclic hydrocarbons with a maximum of 34 carbon atoms, and said heterocyclic alcohols are mono- or polycyclic cycloaliphatic or aliphatic cycloaliphatic alcohols interrupted in their carbon atom chain or ring by one or more heteroatoms chosen from the group formed by nitrogen, oxygen and sulfur, or wherein the alcohols of the cycloaliphatic or aliphatic cycloaliphatic series are derived from mono or polycyclic carbohydrates, and have a maximum of 34 carbon atoms, and may be unsubstituted and may contain one or more substituents, mentioned above for the aliphatic alcohols, or the aliphatic-cycloaliphatic polycyclic alcohols sterols, cholic acids and steroids, or wherein the heterocyclic alcohols are derivatives of the abovesaid cycloaliphatic or aliphatic-cycloaliphatic alcohols, wherein the linear or cyclic chains are interrupted by one to three hetereo atoms chosen from the group formed by - O -, - S -, - N and -NH, as well as genins, digitoxigenin, gitoxigenin, digoxigenin, strophanthidin, tigogenin saponins and vitamin alcohols; and the third portion of carboxyl groups if present is either salified or in form of the free acid.
Claim 2
Dependent Claim 26 words
The cross-linked hyaluronic acid product according to claim 1, wherein each of the carboxyl groups of said hyaluronic acid are ester bonded to a hydroxyl group.
Claim 3
Dependent Claim 28 words
The cross-linked hyaluronic acid product according to claim 1, wherein between 1% and 60% of the carboxyl groups of said hyaluronic acid are cross-linked to a hydroxyl group.
Claim 4
Dependent Claim 27 words
The cross-linked hyaluronic acid product according to anyone of claims 1 to 3, wherein the percentage of carboxyl groups involved in crosslinking ranges between 15% and 30%.
Claim 5
Dependent Claim 103 words
The cross-linked hyaluronic acid product according to claims 1-4, wherein said alcohol is an alcohol with a maximum of 32 carbon atoms and, in the case of alcohols substituted by functional groups, the hydrocarbyl radicals of the amine groups, ether, ester, thioether, thioester, acetal, ketal, represent alkyl groups with a maximum of 4 carbon atoms and in the esterified carboxy groups and in the substituted carbamidic groups the hydrocarbyl groups are alkyl groups with the same number of carbon atoms, and in which the substituted amino or carbamidic groups may also be alkyleneamino or alkylenecarbamidic groups with a maximum of 8 carbon atoms.
Claim 6
Dependent Claim 45 words
The cross-linked hyaluronic acid product according to claim 5, wherein said alcohol is ethyl, propyl, isopropyl, N-butyl, isobutyl, tert-butyl alcohols, an amyl, pentyl, hexyl or octyl alcohol, ethyleneglycol, propyleneglycol, butyleneglycol, glycerin, tartronic alcohol, lactic acid, glycolic acid, malic acid, a tartaric acid or citric acid.
Claim 7
Dependent Claim 72 words
The cross-linked hyaluronic acid product according to claims 1-4, wherein said heterocyclic alcohols are selected from the group consisting of alkaloids, phenylethylamines, phenothiazine drugs, thioxanthene drugs, sulfamidics, meprophendiol, opipramol, oxypendil; carbetidine and phenoperidine and methadol; etodroxizine; benzhydrol and diphemethoxidine; hydroxyzine; cinnamedrine, diphylline, mephenesin, methocarbamol, chlorphenesin, 2,2-diethyl-1,3-propanediol, guaifenesin, idrocilamide; dipyridamole and oxyfedrine; propanolol, timolol, pindolol, bupranolol, atenolol, metoprolol, practolol; 6-azauridine, cytarabine, floxuridine; chloramphenicol, thiamphenicol, erythromycin, oleandomycin, lincomycin; idoxuridine; isonicotinyl alcohol; sulocarbilate and tiaramide.
Claim 8
Dependent Claim 28 words
A salt of a cross-linked hyaluronic acid product according to anyone of claims 1 to 7, with an alkaline or alkaline earth metal, magnesium, aluminum or an amine.
Claim 9
Dependent Claim 10 words
A salt according to claim 8, with sodium or ammonium.
Claim 10
Dependent Claim 14 words
A salt according to claim 8, wherein said amine is a therapeutically acceptable base.
Claim 11
Dependent Claim 14 words
A salt according to claim 8, wherein said amine is a therapeutically active base.
Claim 12
Dependent Claim 105 words
A salt according to claim 8, wherein said amine is pharmacologically inactive and is selected from the group consisting of mono-, di- and tri-alkylamines with a maximum of 18 carbon atoms, arylalkylamines with a maximum of 18 carbon atoms in the aliphatic part and with a benzene group as an aromatic part, optionally substituted by between 1 and 3 methyl groups or halogen atoms or hydroxyl groups, alkyleneamines with cycles of between 4 and 6 carbon atoms optionally interrupted in the cycle by heteroatoms chosen from the group consisting of O and S, and amines of all these types substituted by amino or hydroxy functions.
Claim 13
Dependent Claim 240 words
A compound according to claim 1, selected from the group consisting of: - hyaluronic acid cross-linked to an extent of 1% of the carboxy groups and salified with sodium to an extent of 99%; - hyaluronic acid cross-linked to an extent of 5% of the carboxy groups and salified with sodium to an extent of 95%; - hyaluronic acid cross-linked to an extent of 10% of the carboxy groups and salified with sodium to an extent of 90%; - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups and salified with sodium to an extent of 75%; - hyaluronic acid cross-linked to an extent of 50% of the carboxy groups and salified with sodium to an extent of 50%; - hyaluronic acid cross-linked to an extent of 75% of the carboxy groups and salified with sodium to an extent of 25%; - hyaluronic acid cross-linked to an extent of 100% of the carboxy groups; - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups, esterified to an extent of 25% with ethanol and salified with sodium to an extent of 50%; - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups, esterified to an extent of 50% with ethanol and salified with sodium to an extent of 25%; and - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups and esterified with ethanol to an extent of 75%.
Claim 14
Dependent Claim 176 words
A compound according to claim 11 selected from the group consisting of: - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups, esterified to an extent of 20% with cortisone and salified with sodium to an extent of 55%; - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups, esterified with cortisone to an extent of 20% and with ethanol to an extent of 25% and salified with sodium to an extent of 30%; - hyaluronic acid cross-linked to an extent of 10% of the carboxy groups, esterified with cortisone to an extent of 20% and with ethanol to an extent of 70%; - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups and salified with carteololo to an extent of 75%; - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups and salified to an extent of 75% with kanamycin; and - hyaluronic acid cross-linked to an extent of 25% of the carboxy groups and salified with amikacin to an extent of 75%.
Claim 15
Dependent Claim 18 words
A pharmaceutical composition comprising as an active ingredient a compound according to claim 11 together with an excipient.
Claim 16
Dependent Claim 34 words
A medicament comprising: (1) a pharmacologically active substance or a mixture of pharmacologically active substances; and (2) a vehicle comprised of a cross-linked hyaluronic acid product according to anyone of claims 1 to 4.
Claim 17
Dependent Claim 19 words
A medicament according to claim 16, in which component (1) is a substance for oral, parenteral or topical use.
Claim 18
Dependent Claim 20 words
A medicament according to claim 17, wherein the component (1) is an anesthetic, analgesic, antiinflammatory, vasocontrictory antibiotic/antibacterial or antiviral agent.
Claim 19
Dependent Claim 17 words
A cosmetic article containing a cross-linked hyaluronic acid product according to anyone of claims 1 to 4.
Claim 20
Dependent Claim 18 words
A sanitary or surgical article containing a hyaluronic acid product according to anyone of claims 1 to 4.
Claim 21
Dependent Claim 20 words
A sanitary or surgical article according to claim 20, comprised of threads or films of a cross-linked hyaluronic acid product.
Claim 22
Dependent Claim 18 words
A sanitary or surgical article according to claim 21, comprised of capsules for the subcutaneous implantation of medicaments.
Claim 23
Dependent Claim 18 words
A sanitary or surgical article according to claim 21, comprised of microcapsules for subcutaneous, intramuscular or intravenous injection.
Claim 24
Dependent Claim 19 words
A sanitary or surgical article according to claim 20, comprised of sponges for the medication of wounds and lesions.
Claim 25
Dependent Claim 85 words
A process for the preparation of cross-linked hyaluronic acid products as defined in claims 1-14 which comprises: (a) treating hyaluronic acid with an activating agent selected from those generally used in peptide synthesis or 2-halogen-N-C₁-C₆ alkyl-pyridine or chloroacetonitrile to activate carboxy groups in said hyaluronic acid to form intermediate activated hyaluronic acid derivatives; and (b) subjecting said intermediate activated hyaluronic derivatives to heat or irradiation to produce cross-linked hyaluronic acid whereby the synthesis is carried out in an aprotic solvent at a temperature of 0-150°C.
Claim 26
Dependent Claim 21 words
A process according to claim 25, wherein at least a portion of the carboxy groups in said hyaluronic acid are salified.
Claim 27
Dependent Claim 29 words
A process according to claim 26, wherein said at least a portion of carboxy groups are salified with an alkaline or alkaline earth metal, or with a quaternary ammonium.
Claim 28
Dependent Claim 21 words
A process according to claim 25, wherein said treatment with an activating agent is performed in the presence of a catalyst.
Claim 29
Dependent Claim 20 words
A process according to any of claims 25-28, wherein said activating agent is a carbodiimide, ethoxyacetylene, Woodward's reagent, or chloroacetonitryl.
Claim 30
Dependent Claim 40 words
A process according to any of claims 25-28, wherein said activating agent is a 2-halogen-N-alkylpyridinium salt, in which the halogen is selected from the group consisting of chlorine and bromine and the alkyl has a maximum of 6 carbon atoms.
Claim 31
Dependent Claim 33 words
A process according to claim 30, wherein said activating agent is a chloride of 2-chloro-N-methyl-pyridine and reacts with a tetrabutyl-ammonium salt of the hyaluronic acid in the presence of a tertiary amine base.
Claim 32
Dependent Claim 34 words
A process according to claim 25, wherein said organic involving the aprotic solvent is a dialkylsulfoxide or a dialkylamide of a lower aliphatic alcohol with an alkyl having a maximum of 6 carbon atoms.
Claim 33
Dependent Claim 13 words
A process according to claim 25, wherein dimethylsulfoxide is used as said solvent.
Claim 34
Dependent Claim 16 words
A process according to claim 25 in which the reaction is carried out at room temperature.
Claim 35
Dependent Claim 40 words
A process according to any one of claims 25-34, wherein subsequent to said cross-linking reaction, at least a portion of any remaining free carboxyl groups in said cross-linked hyaluronic acid are salified or esterified with a mono- or polyvalent alcohol.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag